| Your Current Location : Fund Card : Portfolio Classification |
 |
|
|
| |
| WhiteOak Capital Pharma and Healthcare Fund (G) Direct |
| [Equity: Sectoral] |
|
| |
|
|
| Instruments Breakdown |
| Instruments |
Composition |
| Current Asset |
1.26 |
| Equity |
93.64 |
| Treasury Bill |
2.52 |
| Trep |
2.58 |
|
| |
| Concentration Analysis |
| Top 5 Holdings |
31.14% |
| Top 10 Holdings |
46.30% |
| Top 25 Holdings |
76.46% |
|
|
|
| |
| Sector Analysis |
| Sector/Ratings |
Net Asset(%) |
| Pharma & Biotech |
59.39 |
| Healthcare |
28.88 |
| Cash |
3.84 |
| Chemicals |
3.36 |
| SOV |
2.52 |
| Consumer Durables |
2.01 |
|
|
|
|
|
| Portfolio Metrics |
|
| PB Ratio |
7.73 |
| PE Ratio |
53.02 |
|
| |
| Top 25 Holdings |
|
|
| Holdings |
Net Asset(%) |
| Divis Laboratories Ltd. |
8.45 |
| Sun Pharmaceutical Industries Ltd. |
7.40 |
| Torrent Pharmaceuticals Ltd. |
6.78 |
| Apollo Hospitals Enterprises Ltd. |
4.73 |
| Laurus Labs Limited |
3.78 |
| Sai Life Sciences Limited |
3.32 |
| Cipla Ltd. |
3.25 |
| Max Healthcare Institute Limited |
3.05 |
| Neuland Laboratories Limited. |
2.88 |
| Ipca Laboratories Ltd. |
2.66 |
| Clearing Corporation of India Ltd |
2.58 |
| Zydus Lifesciences Limited |
2.58 |
| Corona Remedies Limited |
2.35 |
| Dr. Lal Pathlabs Limited |
2.35 |
| Thyrocare Technologies Limited |
2.31 |
| Aurobindo Pharma Ltd. |
2.21 |
| Shaily Engineering Plastics Ltd. |
2.01 |
| Global Health Limited |
1.92 |
| Krishna Institute of Medical Sciences Limited |
1.92 |
| Narayana Hrudayalaya Limited |
1.76 |
| Ajanta Pharma Ltd. |
1.72 |
| Anthem Biosciences Limited |
1.68 |
| Fortis Healthcare Ltd |
1.65 |
| Vijaya Diagnostic Centre Limited |
1.59 |
| Navin Fluorine International Limited |
1.53 |
|
|
|
| |
|
| |
| Sector Analysis Graphical Mode |
|
| |
|
|
| |
|
 |
| |
|
|
|
